

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.59752941 |
| 2 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.55904636 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.48251301 |
| 4 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.47365005 |
| 5 | oxygen transport (GO:0015671) | 4.42580693 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.25279659 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.21962082 |
| 8 | gas transport (GO:0015669) | 4.02861457 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.98466535 |
| 10 | response to muramyl dipeptide (GO:0032495) | 3.92944522 |
| 11 | NIK/NF-kappaB signaling (GO:0038061) | 3.89126584 |
| 12 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.85197884 |
| 13 | erythrocyte development (GO:0048821) | 3.85054889 |
| 14 | erythrocyte maturation (GO:0043249) | 3.83767560 |
| 15 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.83237374 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.81414590 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.81414590 |
| 18 | response to peptidoglycan (GO:0032494) | 3.77438138 |
| 19 | myeloid dendritic cell differentiation (GO:0043011) | 3.70660446 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 3.70543303 |
| 21 | myeloid dendritic cell activation (GO:0001773) | 3.66271081 |
| 22 | granulocyte activation (GO:0036230) | 3.59229874 |
| 23 | positive regulation of granulocyte differentiation (GO:0030854) | 3.57507921 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 3.57376001 |
| 25 | neutrophil activation (GO:0042119) | 3.53993963 |
| 26 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.46668495 |
| 27 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.44404366 |
| 28 | Peyers patch development (GO:0048541) | 3.44404366 |
| 29 | regulation of interferon-alpha production (GO:0032647) | 3.43289846 |
| 30 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.41883291 |
| 31 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.41883291 |
| 32 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.41883291 |
| 33 | modulation by symbiont of host immune response (GO:0052553) | 3.41883291 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 3.41883291 |
| 35 | modulation by symbiont of host defense response (GO:0052031) | 3.41883291 |
| 36 | T cell migration (GO:0072678) | 3.34716370 |
| 37 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.33926190 |
| 38 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.33771626 |
| 39 | leukocyte aggregation (GO:0070486) | 3.33707678 |
| 40 | response to type I interferon (GO:0034340) | 3.33552694 |
| 41 | type I interferon signaling pathway (GO:0060337) | 3.32234373 |
| 42 | cellular response to type I interferon (GO:0071357) | 3.32234373 |
| 43 | positive thymic T cell selection (GO:0045059) | 3.29628747 |
| 44 | response to interleukin-15 (GO:0070672) | 3.28595761 |
| 45 | interferon-gamma production (GO:0032609) | 3.26416712 |
| 46 | germinal center formation (GO:0002467) | 3.25390403 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.24426902 |
| 48 | detection of other organism (GO:0098543) | 3.21589713 |
| 49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.21286534 |
| 50 | definitive hemopoiesis (GO:0060216) | 3.17252322 |
| 51 | positive regulation of interleukin-2 production (GO:0032743) | 3.16470365 |
| 52 | regulation of gamma-delta T cell activation (GO:0046643) | 3.16047359 |
| 53 | respiratory burst (GO:0045730) | 3.13810492 |
| 54 | positive regulation of interleukin-12 production (GO:0032735) | 3.11697571 |
| 55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.11543948 |
| 56 | positive regulation of antigen processing and presentation (GO:0002579) | 3.11252150 |
| 57 | regulation of erythrocyte differentiation (GO:0045646) | 3.10635449 |
| 58 | defense response to protozoan (GO:0042832) | 3.10400207 |
| 59 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.09938491 |
| 60 | detection of bacterium (GO:0016045) | 3.09682770 |
| 61 | B cell mediated immunity (GO:0019724) | 3.08988492 |
| 62 | macrophage activation involved in immune response (GO:0002281) | 3.05813501 |
| 63 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.05599040 |
| 64 | myeloid cell development (GO:0061515) | 3.04888925 |
| 65 | positive regulation of B cell differentiation (GO:0045579) | 3.04430153 |
| 66 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.03340128 |
| 67 | natural killer cell mediated immunity (GO:0002228) | 3.03340128 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 3.02114446 |
| 69 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.01321706 |
| 70 | response to protozoan (GO:0001562) | 2.99856060 |
| 71 | positive regulation of isotype switching (GO:0045830) | 2.98787846 |
| 72 | regulation of RIG-I signaling pathway (GO:0039535) | 2.97835574 |
| 73 | B cell receptor signaling pathway (GO:0050853) | 2.97307587 |
| 74 | positive regulation of interferon-beta production (GO:0032728) | 2.97292387 |
| 75 | cellular response to zinc ion (GO:0071294) | 2.97093503 |
| 76 | positive T cell selection (GO:0043368) | 2.96241251 |
| 77 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.95512452 |
| 78 | positive regulation of B cell mediated immunity (GO:0002714) | 2.95512452 |
| 79 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.95191698 |
| 80 | cellular response to interferon-beta (GO:0035458) | 2.94975990 |
| 81 | granulocyte differentiation (GO:0030851) | 2.92507593 |
| 82 | thymic T cell selection (GO:0045061) | 2.91040693 |
| 83 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.89433118 |
| 84 | T cell selection (GO:0045058) | 2.88575608 |
| 85 | dendritic cell differentiation (GO:0097028) | 2.88110961 |
| 86 | regulation of hypersensitivity (GO:0002883) | 2.87811819 |
| 87 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.87256589 |
| 88 | negative regulation of interleukin-12 production (GO:0032695) | 2.86898523 |
| 89 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.86847293 |
| 90 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.86573897 |
| 91 | response to interferon-beta (GO:0035456) | 2.85507833 |
| 92 | megakaryocyte development (GO:0035855) | 2.85314865 |
| 93 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.84963925 |
| 94 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.84699215 |
| 95 | negative thymic T cell selection (GO:0045060) | 2.84600986 |
| 96 | regulation of B cell differentiation (GO:0045577) | 2.84525294 |
| 97 | natural killer cell differentiation (GO:0001779) | 2.84087595 |
| 98 | regulation of interleukin-12 production (GO:0032655) | 2.83865693 |
| 99 | negative regulation of viral genome replication (GO:0045071) | 2.82962083 |
| 100 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.82429372 |
| 101 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.79586548 |
| 102 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.79466333 |
| 103 | natural killer cell activation (GO:0030101) | 2.78413441 |
| 104 | leukocyte degranulation (GO:0043299) | 2.77943421 |
| 105 | monocyte chemotaxis (GO:0002548) | 2.77743984 |
| 106 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.76573950 |
| 107 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.76409933 |
| 108 | positive regulation of humoral immune response (GO:0002922) | 2.76334188 |
| 109 | regulation of antigen processing and presentation (GO:0002577) | 2.76198454 |
| 110 | regulation of chronic inflammatory response (GO:0002676) | 2.76131190 |
| 111 | regulation of granulocyte differentiation (GO:0030852) | 2.75746794 |
| 112 | positive regulation of interleukin-17 production (GO:0032740) | 2.75504661 |
| 113 | regulation of histone H3-K27 methylation (GO:0061085) | 2.74265453 |
| 114 | cellular extravasation (GO:0045123) | 2.74133561 |
| 115 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.74001959 |
| 116 | negative T cell selection (GO:0043383) | 2.72689023 |
| 117 | regulation of activation of Janus kinase activity (GO:0010533) | 2.72240728 |
| 118 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.71924638 |
| 119 | detection of external biotic stimulus (GO:0098581) | 2.71907053 |
| 120 | tolerance induction (GO:0002507) | 2.71644107 |
| 121 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.71311149 |
| 122 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.71259764 |
| 123 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.71231534 |
| 124 | myeloid cell activation involved in immune response (GO:0002275) | 2.70876920 |
| 125 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.69838037 |
| 126 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.69642593 |
| 127 | regulation of fever generation (GO:0031620) | 2.69637424 |
| 128 | cytokine secretion (GO:0050663) | 2.69420430 |
| 129 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.69361165 |
| 130 | T-helper 1 type immune response (GO:0042088) | 2.69255540 |
| 131 | positive regulation of heat generation (GO:0031652) | 2.69159297 |
| 132 | negative regulation of cell killing (GO:0031342) | 2.68944647 |
| 133 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.68944647 |
| 134 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.68937564 |
| 135 | positive regulation of DNA recombination (GO:0045911) | 2.67595287 |
| 136 | regulation of T-helper cell differentiation (GO:0045622) | 2.67226514 |
| 137 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.66719491 |
| 138 | regulation of necroptotic process (GO:0060544) | 2.66428939 |
| 139 | regulation of T-helper 1 type immune response (GO:0002825) | 2.66403855 |
| 140 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.66146571 |
| 141 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.65592948 |
| 142 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.65147179 |
| 143 | hemoglobin metabolic process (GO:0020027) | 2.65129023 |
| 144 | positive regulation of interferon-gamma production (GO:0032729) | 2.64812361 |
| 145 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.63658870 |
| 146 | modulation by symbiont of host cellular process (GO:0044068) | 2.63645946 |
| 147 | modulation by virus of host process (GO:0019054) | 2.62272176 |
| 148 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.57044022 |
| 149 | detection of molecule of bacterial origin (GO:0032490) | 2.56966579 |
| 150 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.54886565 |
| 151 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.50377401 |
| 152 | regulation of leukocyte degranulation (GO:0043300) | 2.50184622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.74749375 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.51749940 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.81996977 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.46122589 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.97071487 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.81121007 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.48136287 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.37424200 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.22433120 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.21295032 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15287958 |
| 12 | * GATA1_19941826_ChIP-Seq_K562_Human | 3.08532893 |
| 13 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.07188425 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.93556742 |
| 15 | * E2F7_22180533_ChIP-Seq_HELA_Human | 2.90220329 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.90139543 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.90013783 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.81414890 |
| 19 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.70918233 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.49243675 |
| 21 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.34774752 |
| 22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.27951412 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.15697944 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 2.12526350 |
| 25 | * MAF_26560356_Chip-Seq_TH1_Human | 2.09700597 |
| 26 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.09231905 |
| 27 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08008309 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.04590190 |
| 29 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.04330513 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.01286570 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99150974 |
| 32 | * MYB_26560356_Chip-Seq_TH1_Human | 1.98223340 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.95157434 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93004013 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90955863 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.87996638 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.86714980 |
| 38 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84999725 |
| 39 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81532174 |
| 40 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.65291611 |
| 41 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62153867 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.58026609 |
| 43 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.54188831 |
| 44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.52673836 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48944353 |
| 46 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47350835 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42692692 |
| 48 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39476664 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37946918 |
| 50 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37542358 |
| 51 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36462817 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36392467 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.35668200 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34602846 |
| 55 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.30144311 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.27104152 |
| 57 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26381840 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25678262 |
| 59 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24418812 |
| 60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23001476 |
| 61 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22899195 |
| 62 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22827757 |
| 63 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16648745 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16020189 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15842553 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15393219 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15023236 |
| 68 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14773435 |
| 69 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14700214 |
| 70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14423495 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13510581 |
| 72 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10689506 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09693673 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08600147 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08400035 |
| 76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07758715 |
| 77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07360819 |
| 78 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07056502 |
| 79 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.06439455 |
| 80 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06039764 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02347123 |
| 82 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.01764109 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01520746 |
| 84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.01502762 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00191916 |
| 86 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.99978764 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99043246 |
| 88 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.98911614 |
| 89 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98884188 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96710031 |
| 91 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.95847077 |
| 92 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.93354980 |
| 93 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.92771797 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92642643 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92293098 |
| 96 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92142910 |
| 97 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.91528342 |
| 98 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.90364419 |
| 99 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90198276 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89217819 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87112227 |
| 102 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.86919898 |
| 103 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.85040561 |
| 104 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.84857489 |
| 105 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82691019 |
| 106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82353879 |
| 107 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.80606059 |
| 108 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80429132 |
| 109 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.78892610 |
| 110 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.77425700 |
| 111 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.76719564 |
| 112 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75532211 |
| 113 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.75460822 |
| 114 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.74159356 |
| 115 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.74159356 |
| 116 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.74159356 |
| 117 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.73065100 |
| 118 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.70985604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.30410172 |
| 2 | MP0003436_decreased_susceptibility_to | 3.57657091 |
| 3 | MP0009785_altered_susceptibility_to | 3.37586711 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.32952342 |
| 5 | MP0005671_abnormal_response_to | 3.24230768 |
| 6 | MP0000685_abnormal_immune_system | 3.16891629 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.11080039 |
| 8 | MP0005387_immune_system_phenotype | 2.93383208 |
| 9 | MP0001790_abnormal_immune_system | 2.93383208 |
| 10 | MP0003303_peritoneal_inflammation | 2.88077972 |
| 11 | MP0001800_abnormal_humoral_immune | 2.83603191 |
| 12 | MP0005025_abnormal_response_to | 2.79313962 |
| 13 | MP0005451_abnormal_body_composition | 2.75438029 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.68108818 |
| 15 | MP0002419_abnormal_innate_immunity | 2.63459143 |
| 16 | MP0002723_abnormal_immune_serum | 2.62593232 |
| 17 | MP0004510_myositis | 2.60098391 |
| 18 | MP0004147_increased_porphyrin_level | 2.59899324 |
| 19 | MP0006082_CNS_inflammation | 2.59557836 |
| 20 | MP0003724_increased_susceptibility_to | 2.51644169 |
| 21 | * MP0001819_abnormal_immune_cell | 2.42526780 |
| 22 | * MP0002420_abnormal_adaptive_immunity | 2.40985792 |
| 23 | MP0002405_respiratory_system_inflammati | 2.26513628 |
| 24 | * MP0002398_abnormal_bone_marrow | 2.07699598 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.06654428 |
| 26 | MP0001853_heart_inflammation | 2.05700709 |
| 27 | MP0010155_abnormal_intestine_physiology | 2.02803734 |
| 28 | MP0002006_tumorigenesis | 1.98532791 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.97419040 |
| 30 | * MP0000716_abnormal_immune_system | 1.92409349 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.92190502 |
| 32 | MP0004947_skin_inflammation | 1.91851654 |
| 33 | MP0009278_abnormal_bone_marrow | 1.87009524 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.86522894 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.86522894 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.79843723 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.79601424 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.78923726 |
| 39 | MP0003448_altered_tumor_morphology | 1.78508157 |
| 40 | MP0008260_abnormal_autophagy | 1.76541887 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.71375200 |
| 42 | MP0005083_abnormal_biliary_tract | 1.68188346 |
| 43 | MP0002722_abnormal_immune_system | 1.67103317 |
| 44 | * MP0002429_abnormal_blood_cell | 1.62196306 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.62140999 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.61255688 |
| 47 | MP0005310_abnormal_salivary_gland | 1.55180680 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.53297707 |
| 49 | MP0000858_altered_metastatic_potential | 1.52779271 |
| 50 | MP0004808_abnormal_hematopoietic_stem | 1.48237030 |
| 51 | MP0009764_decreased_sensitivity_to | 1.47859323 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.45789615 |
| 53 | MP0008057_abnormal_DNA_replication | 1.44833532 |
| 54 | MP0000490_abnormal_crypts_of | 1.38269198 |
| 55 | MP0008469_abnormal_protein_level | 1.35952398 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.35714969 |
| 57 | MP0010307_abnormal_tumor_latency | 1.32919633 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 1.32578995 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.31776493 |
| 60 | MP0001873_stomach_inflammation | 1.29373490 |
| 61 | MP0003866_abnormal_defecation | 1.26409710 |
| 62 | MP0008995_early_reproductive_senescence | 1.21795721 |
| 63 | MP0000343_altered_response_to | 1.18666628 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.15146317 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.13000733 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.12992938 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.11945387 |
| 68 | MP0002254_reproductive_system_inflammat | 1.08848998 |
| 69 | MP0005174_abnormal_tail_pigmentation | 1.06006303 |
| 70 | MP0002009_preneoplasia | 1.04127579 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.03954661 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 1.03238138 |
| 73 | MP0003828_pulmonary_edema | 1.00305909 |
| 74 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98451544 |
| 75 | MP0002933_joint_inflammation | 0.96159365 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.93253247 |
| 77 | MP0002019_abnormal_tumor_incidence | 0.92416488 |
| 78 | MP0001851_eye_inflammation | 0.92141302 |
| 79 | MP0003111_abnormal_nucleus_morphology | 0.88519147 |
| 80 | MP0000609_abnormal_liver_physiology | 0.87272502 |
| 81 | MP0008004_abnormal_stomach_pH | 0.86661565 |
| 82 | MP0005390_skeleton_phenotype | 0.86261251 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 0.86082615 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 0.85075393 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.83186319 |
| 86 | MP0009763_increased_sensitivity_to | 0.82623281 |
| 87 | MP0008007_abnormal_cellular_replicative | 0.82238855 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.80815633 |
| 89 | MP0003075_altered_response_to | 0.80224127 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.79987788 |
| 91 | MP0004883_abnormal_blood_vessel | 0.79721712 |
| 92 | MP0005058_abnormal_lysosome_morphology | 0.77901245 |
| 93 | MP0000604_amyloidosis | 0.77573599 |
| 94 | MP0009931_abnormal_skin_appearance | 0.76858963 |
| 95 | MP0002132_abnormal_respiratory_system | 0.76667216 |
| 96 | MP0003077_abnormal_cell_cycle | 0.75408953 |
| 97 | MP0005166_decreased_susceptibility_to | 0.71501705 |
| 98 | MP0003690_abnormal_glial_cell | 0.70490478 |
| 99 | MP0010094_abnormal_chromosome_stability | 0.67712474 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.67677260 |
| 101 | MP0002332_abnormal_exercise_endurance | 0.67085448 |
| 102 | MP0000371_diluted_coat_color | 0.65918954 |
| 103 | MP0003186_abnormal_redox_activity | 0.65571549 |
| 104 | MP0000249_abnormal_blood_vessel | 0.64347059 |
| 105 | MP0001663_abnormal_digestive_system | 0.64305712 |
| 106 | MP0002139_abnormal_hepatobiliary_system | 0.63728346 |
| 107 | MP0004381_abnormal_hair_follicle | 0.63710547 |
| 108 | MP0009840_abnormal_foam_cell | 0.61291300 |
| 109 | MP0001881_abnormal_mammary_gland | 0.61056709 |
| 110 | MP0008058_abnormal_DNA_repair | 0.60221568 |
| 111 | MP0000313_abnormal_cell_death | 0.60206373 |
| 112 | MP0009115_abnormal_fat_cell | 0.59627212 |
| 113 | MP0005636_abnormal_mineral_homeostasis | 0.59160454 |
| 114 | MP0005023_abnormal_wound_healing | 0.58969737 |
| 115 | MP0002163_abnormal_gland_morphology | 0.58526513 |
| 116 | MP0005621_abnormal_cell_physiology | 0.57944676 |
| 117 | MP0000627_abnormal_mammary_gland | 0.57753363 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.57409176 |
| 119 | MP0003693_abnormal_embryo_hatching | 0.57251273 |
| 120 | MP0003795_abnormal_bone_structure | 0.56960654 |
| 121 | MP0001216_abnormal_epidermal_layer | 0.56832573 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.56114708 |
| 123 | MP0005164_abnormal_response_to | 0.56077211 |
| 124 | MP0003091_abnormal_cell_migration | 0.55175612 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.53261760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.19455944 |
| 2 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.78195482 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.69946012 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.28165202 |
| 5 | Myositis (HP:0100614) | 4.86303716 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.82398747 |
| 7 | Optic neuritis (HP:0100653) | 4.82398747 |
| 8 | Orchitis (HP:0100796) | 4.64026351 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.47138775 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.44184958 |
| 11 | Poikilocytosis (HP:0004447) | 4.38224960 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.22376559 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.19654351 |
| 14 | Reticulocytosis (HP:0001923) | 4.19195609 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 4.07419676 |
| 16 | Cholecystitis (HP:0001082) | 3.95946751 |
| 17 | Abnormal gallbladder physiology (HP:0012438) | 3.95946751 |
| 18 | Polycythemia (HP:0001901) | 3.95788285 |
| 19 | Stomatitis (HP:0010280) | 3.82533123 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.82413976 |
| 21 | Vasculitis (HP:0002633) | 3.68276397 |
| 22 | Recurrent viral infections (HP:0004429) | 3.66907147 |
| 23 | Increased IgM level (HP:0003496) | 3.56600568 |
| 24 | Cellulitis (HP:0100658) | 3.50974937 |
| 25 | Pustule (HP:0200039) | 3.45075903 |
| 26 | Obstructive lung disease (HP:0006536) | 3.43968505 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.43968505 |
| 28 | Recurrent skin infections (HP:0001581) | 3.41314726 |
| 29 | Hypertensive crisis (HP:0100735) | 3.37925059 |
| 30 | Meningitis (HP:0001287) | 3.36234863 |
| 31 | Hypochromic microcytic anemia (HP:0004840) | 3.27788267 |
| 32 | Petechiae (HP:0000967) | 3.17031578 |
| 33 | Keratoconjunctivitis sicca (HP:0001097) | 3.15412032 |
| 34 | Pulmonary infiltrates (HP:0002113) | 3.12713603 |
| 35 | Gingivitis (HP:0000230) | 3.11473803 |
| 36 | Microcytic anemia (HP:0001935) | 3.10857008 |
| 37 | Abnormality of T cell number (HP:0011839) | 3.09678016 |
| 38 | Cholelithiasis (HP:0001081) | 3.03401467 |
| 39 | Abnormal hemoglobin (HP:0011902) | 3.03178248 |
| 40 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.01076466 |
| 41 | Arterial thrombosis (HP:0004420) | 2.98819927 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 2.98718598 |
| 43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.98718598 |
| 44 | Abnormality of reticulocytes (HP:0004312) | 2.96127285 |
| 45 | Keratoconjunctivitis (HP:0001096) | 2.94334411 |
| 46 | Chronic otitis media (HP:0000389) | 2.93018528 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.92136785 |
| 48 | Leukocytosis (HP:0001974) | 2.87394780 |
| 49 | T lymphocytopenia (HP:0005403) | 2.87063173 |
| 50 | IgM deficiency (HP:0002850) | 2.86466334 |
| 51 | Abnormality of T cells (HP:0002843) | 2.80690883 |
| 52 | Acanthocytosis (HP:0001927) | 2.79214127 |
| 53 | Nasal polyposis (HP:0100582) | 2.76544619 |
| 54 | Periodontitis (HP:0000704) | 2.74428690 |
| 55 | Recurrent bronchitis (HP:0002837) | 2.73078180 |
| 56 | Increased serum ferritin (HP:0003281) | 2.72640354 |
| 57 | Prostate neoplasm (HP:0100787) | 2.72487586 |
| 58 | Thrombocytosis (HP:0001894) | 2.72144098 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.67248877 |
| 60 | Abnormality of T cell physiology (HP:0011840) | 2.62857660 |
| 61 | Hemoptysis (HP:0002105) | 2.62570185 |
| 62 | Abnormality of iron homeostasis (HP:0011031) | 2.61029993 |
| 63 | Abnormal gallbladder morphology (HP:0012437) | 2.60743740 |
| 64 | Osteomyelitis (HP:0002754) | 2.60650268 |
| 65 | Hypergammaglobulinemia (HP:0010702) | 2.59387109 |
| 66 | Gastrointestinal infarctions (HP:0005244) | 2.58346188 |
| 67 | Increased IgE level (HP:0003212) | 2.58286131 |
| 68 | Agammaglobulinemia (HP:0004432) | 2.57142720 |
| 69 | Gingival bleeding (HP:0000225) | 2.56225025 |
| 70 | Urticaria (HP:0001025) | 2.54265184 |
| 71 | IgA deficiency (HP:0002720) | 2.53027728 |
| 72 | Slow saccadic eye movements (HP:0000514) | 2.52752258 |
| 73 | Eosinophilia (HP:0001880) | 2.51064417 |
| 74 | Encephalitis (HP:0002383) | 2.51032446 |
| 75 | Seborrheic dermatitis (HP:0001051) | 2.48469150 |
| 76 | Basal ganglia calcification (HP:0002135) | 2.47208027 |
| 77 | Prolonged bleeding time (HP:0003010) | 2.46541886 |
| 78 | Combined immunodeficiency (HP:0005387) | 2.46485320 |
| 79 | Ileus (HP:0002595) | 2.44615021 |
| 80 | Paralysis (HP:0003470) | 2.40848846 |
| 81 | Thyroiditis (HP:0100646) | 2.39286908 |
| 82 | Spontaneous hematomas (HP:0007420) | 2.38057766 |
| 83 | Abnormality of the nasal mucosa (HP:0000433) | 2.37941808 |
| 84 | Abnormality of the prostate (HP:0008775) | 2.34817116 |
| 85 | Abnormality of eosinophils (HP:0001879) | 2.34678604 |
| 86 | Granulocytopenia (HP:0001913) | 2.34198253 |
| 87 | Truncus arteriosus (HP:0001660) | 2.33208691 |
| 88 | Inflammation of the large intestine (HP:0002037) | 2.31922112 |
| 89 | Panhypogammaglobulinemia (HP:0003139) | 2.31161275 |
| 90 | Severe combined immunodeficiency (HP:0004430) | 2.31085987 |
| 91 | Epistaxis (HP:0000421) | 2.30335166 |
| 92 | Recurrent pneumonia (HP:0006532) | 2.29154336 |
| 93 | Vacuolated lymphocytes (HP:0001922) | 2.25522876 |
| 94 | IgG deficiency (HP:0004315) | 2.24442720 |
| 95 | Abnormality of glycolipid metabolism (HP:0010969) | 2.23753683 |
| 96 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.23753683 |
| 97 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.23753683 |
| 98 | Colitis (HP:0002583) | 2.22923685 |
| 99 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.21931848 |
| 100 | Gastrointestinal inflammation (HP:0004386) | 2.21464146 |
| 101 | Anorexia (HP:0002039) | 2.19502002 |
| 102 | Recurrent lower respiratory tract infections (HP:0002783) | 2.18448117 |
| 103 | Hypochromic anemia (HP:0001931) | 2.18089868 |
| 104 | Fatigue (HP:0012378) | 2.17920241 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.17448851 |
| 106 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.17343749 |
| 107 | Abnormality of the fingertips (HP:0001211) | 2.17326308 |
| 108 | Myocardial infarction (HP:0001658) | 2.10091498 |
| 109 | Autoimmune hemolytic anemia (HP:0001890) | 2.10078319 |
| 110 | Gangrene (HP:0100758) | 2.09537167 |
| 111 | Thick nail (HP:0001805) | 2.08936281 |
| 112 | Lymphopenia (HP:0001888) | 2.08764913 |
| 113 | Lymphoma (HP:0002665) | 2.07918258 |
| 114 | Abnormal large intestine physiology (HP:0012700) | 2.07811387 |
| 115 | Bowel incontinence (HP:0002607) | 2.07341595 |
| 116 | Skin ulcer (HP:0200042) | 2.06309640 |
| 117 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.05046136 |
| 118 | Systemic lupus erythematosus (HP:0002725) | 2.03580398 |
| 119 | Premature loss of primary teeth (HP:0006323) | 2.03551492 |
| 120 | Abnormality of the pleura (HP:0002103) | 2.03268749 |
| 121 | Osteolytic defects of the hand bones (HP:0009699) | 2.02739061 |
| 122 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.02739061 |
| 123 | Abnormality of the gallbladder (HP:0005264) | 2.02471611 |
| 124 | Tetraparesis (HP:0002273) | 2.02402768 |
| 125 | Amaurosis fugax (HP:0100576) | 2.02360249 |
| 126 | Acne (HP:0001061) | 2.02216928 |
| 127 | Increased cerebral lipofuscin (HP:0011813) | 2.01746603 |
| 128 | Joint swelling (HP:0001386) | 2.01654661 |
| 129 | Abnormal platelet function (HP:0011869) | 2.00685088 |
| 130 | Impaired platelet aggregation (HP:0003540) | 2.00685088 |
| 131 | Purpura (HP:0000979) | 2.00139554 |
| 132 | Pallor (HP:0000980) | 1.99917423 |
| 133 | Spinal cord lesions (HP:0100561) | 1.97930733 |
| 134 | Syringomyelia (HP:0003396) | 1.97930733 |
| 135 | Glomerulopathy (HP:0100820) | 1.97694828 |
| 136 | Gastrointestinal stroma tumor (HP:0100723) | 1.96496266 |
| 137 | Sepsis (HP:0100806) | 1.95840408 |
| 138 | Hyperbilirubinemia (HP:0002904) | 1.91083548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.90528638 |
| 2 | PRPF4B | 3.60538087 |
| 3 | MAP4K1 | 3.60060056 |
| 4 | TXK | 3.41922373 |
| 5 | IRAK3 | 3.14201539 |
| 6 | IKBKB | 2.96562641 |
| 7 | TBK1 | 2.95860704 |
| 8 | IKBKE | 2.79494689 |
| 9 | JAK3 | 2.72038150 |
| 10 | IRAK4 | 2.67914484 |
| 11 | TYK2 | 2.45736415 |
| 12 | PIM2 | 2.45175267 |
| 13 | BLK | 2.36545337 |
| 14 | RIPK4 | 2.34701180 |
| 15 | TAOK2 | 2.27921049 |
| 16 | CHUK | 2.14825340 |
| 17 | KSR2 | 1.77206448 |
| 18 | ZAP70 | 1.71984018 |
| 19 | JAK1 | 1.70827254 |
| 20 | TAOK3 | 1.66986964 |
| 21 | MAP3K1 | 1.66254119 |
| 22 | * PIM1 | 1.64599070 |
| 23 | TAOK1 | 1.58669432 |
| 24 | BTK | 1.58502943 |
| 25 | SYK | 1.51570736 |
| 26 | NME2 | 1.49535876 |
| 27 | KIT | 1.46161717 |
| 28 | MST4 | 1.39992921 |
| 29 | STK10 | 1.39350681 |
| 30 | MAP3K10 | 1.37074849 |
| 31 | TEC | 1.36080157 |
| 32 | CDK12 | 1.33690627 |
| 33 | CSK | 1.30549198 |
| 34 | FGFR3 | 1.27712660 |
| 35 | STK4 | 1.26793700 |
| 36 | EPHB1 | 1.22542820 |
| 37 | EEF2K | 1.21865462 |
| 38 | HCK | 1.19965075 |
| 39 | LCK | 1.15711900 |
| 40 | MAP3K13 | 1.14808063 |
| 41 | RPS6KA4 | 1.12835804 |
| 42 | PBK | 1.05263751 |
| 43 | RAF1 | 1.03271904 |
| 44 | JAK2 | 1.02537649 |
| 45 | LYN | 1.02270261 |
| 46 | NEK9 | 1.01789111 |
| 47 | TRIB3 | 1.01332450 |
| 48 | TRPM7 | 0.99718268 |
| 49 | ITK | 0.99709158 |
| 50 | CSF1R | 0.98051355 |
| 51 | GRK6 | 0.97976898 |
| 52 | EPHA3 | 0.97969874 |
| 53 | ERN1 | 0.97039327 |
| 54 | BMPR2 | 0.96628699 |
| 55 | MAP3K2 | 0.95463551 |
| 56 | CLK1 | 0.95071165 |
| 57 | FGFR4 | 0.92971631 |
| 58 | MARK3 | 0.88742008 |
| 59 | MAP2K3 | 0.88593841 |
| 60 | STK24 | 0.87482510 |
| 61 | ICK | 0.83744742 |
| 62 | MATK | 0.83405009 |
| 63 | NLK | 0.79464993 |
| 64 | CDK6 | 0.77951789 |
| 65 | SIK3 | 0.76631255 |
| 66 | EIF2AK2 | 0.75959923 |
| 67 | TNK2 | 0.75553955 |
| 68 | YES1 | 0.73656797 |
| 69 | TGFBR2 | 0.73193737 |
| 70 | WNK1 | 0.72800988 |
| 71 | MAP3K11 | 0.70013562 |
| 72 | MAPKAPK2 | 0.68667692 |
| 73 | IRAK1 | 0.68560054 |
| 74 | MAP3K6 | 0.67571070 |
| 75 | MARK2 | 0.66853621 |
| 76 | IRAK2 | 0.65686476 |
| 77 | TESK2 | 0.64706105 |
| 78 | KSR1 | 0.64471533 |
| 79 | SMG1 | 0.63249622 |
| 80 | MAP3K7 | 0.63049725 |
| 81 | RPS6KA6 | 0.62804639 |
| 82 | STK3 | 0.60436318 |
| 83 | CDK4 | 0.59689187 |
| 84 | DYRK3 | 0.59550747 |
| 85 | RPS6KA5 | 0.59075799 |
| 86 | LRRK2 | 0.58270635 |
| 87 | ABL1 | 0.57252742 |
| 88 | CDC42BPA | 0.57042309 |
| 89 | MAPK11 | 0.56507712 |
| 90 | RPS6KA1 | 0.55199413 |
| 91 | PTK6 | 0.52066469 |
| 92 | CAMK1D | 0.51858789 |
| 93 | MAPK12 | 0.49372403 |
| 94 | RPS6KC1 | 0.49320170 |
| 95 | RPS6KL1 | 0.49320170 |
| 96 | ALK | 0.49118142 |
| 97 | ABL2 | 0.45545800 |
| 98 | RPS6KB2 | 0.45333821 |
| 99 | TYRO3 | 0.45332705 |
| 100 | FLT3 | 0.45262029 |
| 101 | SIK2 | 0.44577344 |
| 102 | PRKCD | 0.43848868 |
| 103 | MKNK2 | 0.42828743 |
| 104 | MAP3K3 | 0.42037372 |
| 105 | HIPK2 | 0.41839798 |
| 106 | EIF2AK1 | 0.40750229 |
| 107 | PDK1 | 0.40655574 |
| 108 | MAP3K5 | 0.40337994 |
| 109 | MOS | 0.40099018 |
| 110 | GRK7 | 0.39880444 |
| 111 | BRD4 | 0.38728189 |
| 112 | PLK4 | 0.38360500 |
| 113 | RET | 0.37714335 |
| 114 | RIPK1 | 0.36369833 |
| 115 | FGR | 0.35735845 |
| 116 | SIK1 | 0.35060564 |
| 117 | TGFBR1 | 0.34889284 |
| 118 | PRKCQ | 0.34345157 |
| 119 | EGFR | 0.34235110 |
| 120 | MKNK1 | 0.33623715 |
| 121 | CDK9 | 0.32905899 |
| 122 | FES | 0.32235429 |
| 123 | MAP3K8 | 0.32216347 |
| 124 | MUSK | 0.31262037 |
| 125 | ACVR1B | 0.28481498 |
| 126 | NEK2 | 0.28237626 |
| 127 | ATR | 0.27563523 |
| 128 | TLK1 | 0.27063338 |
| 129 | DYRK1B | 0.27051723 |
| 130 | MAPK3 | 0.26078665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.32910505 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.00096002 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.92794002 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.88606716 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.64425539 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.52554866 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.39624091 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.36719429 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.34026782 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.26780590 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.25637017 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.25396047 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.19215177 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.15826777 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.04236193 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.86382234 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.83182986 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.82803176 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.82308158 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.75865291 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.73235362 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.72557268 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72236507 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69118717 |
| 25 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.68136649 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.65188786 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61392912 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61321552 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.59348510 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.57568809 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.57150706 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55658341 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.47122649 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.39183625 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.32046516 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30765363 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.29718059 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28385486 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.25880694 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19393907 |
| 41 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14921758 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06559442 |
| 43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06461698 |
| 44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.05610351 |
| 45 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03366123 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01113700 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98809235 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97777968 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.94302896 |
| 50 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92985075 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91053389 |
| 52 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.91005036 |
| 53 | Bladder cancer_Homo sapiens_hsa05219 | 0.90158005 |
| 54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88139101 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83307588 |
| 56 | Ribosome_Homo sapiens_hsa03010 | 0.80765706 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79720431 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76404002 |
| 59 | Base excision repair_Homo sapiens_hsa03410 | 0.76321107 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76221059 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75110659 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74744952 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74035602 |
| 64 | DNA replication_Homo sapiens_hsa03030 | 0.71343725 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69598771 |
| 66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66449782 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.66303403 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.65972707 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65796426 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63003186 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61622474 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59757681 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57547084 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.55410296 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55349976 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54266571 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52902074 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.52215699 |
| 79 | Homologous recombination_Homo sapiens_hsa03440 | 0.51688346 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51523992 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49321299 |
| 82 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49118646 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48140510 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47949754 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47017907 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45876520 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45857120 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45784216 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45331479 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45066442 |
| 91 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44585793 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.43608223 |
| 93 | Mismatch repair_Homo sapiens_hsa03430 | 0.43221585 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42603418 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40636795 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39694589 |
| 97 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39668531 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39608864 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39571274 |
| 100 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.39384969 |
| 101 | Spliceosome_Homo sapiens_hsa03040 | 0.39313920 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38926097 |
| 103 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.33946145 |
| 104 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.33466937 |
| 105 | Prostate cancer_Homo sapiens_hsa05215 | 0.33154180 |
| 106 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32052953 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31117559 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30076106 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29710362 |
| 110 | RNA degradation_Homo sapiens_hsa03018 | 0.29697517 |
| 111 | Cell cycle_Homo sapiens_hsa04110 | 0.28631217 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25753514 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25486186 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24913569 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24888452 |
| 116 | Proteasome_Homo sapiens_hsa03050 | 0.24883804 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.24467128 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24228122 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24175877 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24026681 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.23746115 |

